{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T21:09:36Z","timestamp":1766178576932,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1111\/jth.15533","type":"journal-article","created":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T09:03:48Z","timestamp":1632042228000},"page":"3080-3089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Use of novel antithrombotic agents for COVID\u201019: Systematic summary of ongoing randomized controlled trials"],"prefix":"10.1016","volume":"19","author":[{"given":"Azita H.","family":"Talasaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9602-0513","authenticated-orcid":false,"given":"Parham","family":"Sadeghipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Aghakouchakzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6719-4856","authenticated-orcid":false,"given":"Hessam","family":"Kakavand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Ariannejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6445-582X","authenticated-orcid":false,"given":"Jean M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4709-0774","authenticated-orcid":false,"given":"Beverley J.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin W.","family":"Van Tassell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1006-6420","authenticated-orcid":false,"given":"Saskia","family":"Middeldorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1092-7550","authenticated-orcid":false,"given":"Jeffrey I.","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7871-6143","authenticated-orcid":false,"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel Z.","family":"Goldhaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1428-879X","authenticated-orcid":false,"given":"Behnood","family":"Bikdeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1111\/jth.15533_bb0010","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID\u201019 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow\u2010up: JACC state\u2010of\u2010the\u2010art review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1111\/jth.15533_bb0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12185-021-03078-x","article-title":"Ethnic differences in thromboprophylaxis for COVID\u201019 patients: should they be considered?","volume":"113","author":"Iba","year":"2021","journal-title":"Int J Hematol"},{"issue":"4","key":"10.1111\/jth.15533_bb0020","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/jth.15261","article-title":"Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID\u201019 patients: a multicenter retrospective study","volume":"19","author":"Li","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"15","key":"10.1111\/jth.15533_bb0025","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2021.02.035","article-title":"Recent randomized trials of antithrombotic therapy for patients with COVID\u201019: JACC state\u2010of\u2010the\u2010art review","volume":"77","author":"Talasaz","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1111\/jth.15533_bb0030","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically Ill patients with Covid\u201019","volume":"385","year":"2021","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1111\/jth.15533_bb0035","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/jama.2021.4152","volume":"325","author":"Sadeghipour","year":"2021","journal-title":"JAMA"},{"issue":"9","key":"10.1111\/jth.15533_bb0040","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/jth.15450","article-title":"Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID\u201019: a multi\u2010center, open\u2010label, randomised controlled trial. open\u2010label, randomised controlled trial","volume":"19","author":"Perepu","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15533_bb0045","article-title":"Intermediate\u2010dose versus standard\u2010dose prophylactic anticoagulation in patients with COVID\u201019 admitted to the intensive care unit: 90\u2010day results from the INSPIRATION randomized trial","author":"Bikdeli","year":"2021","journal-title":"Thromb Haemost"},{"issue":"10291","key":"10.1111\/jth.15533_bb0050","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID\u201019 and elevated D\u2010dimer concentration (ACTION): an open\u2010label, multicentre, randomised, controlled trial","volume":"397","author":"Lopes","year":"2021","journal-title":"Lancet"},{"issue":"32","key":"10.1111\/jth.15533_bb0055","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1093\/eurheartj\/ehaa500","article-title":"Pulmonary embolism in COVID\u201019 patients: a French multicentre cohort study","volume":"41","author":"Fauvel","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1111\/jth.15533_bb0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1538-7836.2004.00526.x","article-title":"Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor\/factor VIIa, attenuates coagulation and the interleukin\u201010 response in human endotoxemia","volume":"2","author":"De Pont","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1111\/jth.15533_bb0065","first-page":"2059","article-title":"New antithrombotic drugs in acute coronary syndrome","volume":"9","author":"Zwart","year":"2020","journal-title":"Clin Med"},{"issue":"6","key":"10.1111\/jth.15533_bb0070","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.explore.2020.03.007","article-title":"Integrative considerations during the COVID\u201019 pandemic","volume":"16","author":"Alschuler","year":"2020","journal-title":"Explore (NY)"},{"issue":"2","key":"10.1111\/jth.15533_bb0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS\u2010CoV\u20102 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"9","key":"10.1111\/jth.15533_bb0080","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1021\/acsinfecdis.0c00343","article-title":"Old drugs for a new virus: repurposed approaches for combating COVID\u201019","volume":"6","author":"Saul","year":"2020","journal-title":"ACS Infect Dis"},{"issue":"1","key":"10.1111\/jth.15533_bb0085","first-page":"1717","article-title":"Therapeutic effect of ulinastatin on pulmonary fibrosis via downregulation of TGF\u2010\u03b21","volume":"17","author":"Li","year":"2018","journal-title":"TNF\u2010\u03b1 and NF\u2010\u03baB. Mol Med Rep"},{"issue":"8","key":"10.1111\/jth.15533_bb0090","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/CIRCULATIONAHA.120.052824","article-title":"Lack of evidence of ACE2 expression and replicative infection by SARSCoV\u20102 in human endothelial cells","volume":"143","author":"McCracken","year":"2020","journal-title":"Circulation"},{"issue":"32","key":"10.1111\/jth.15533_bb0095","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"COVID\u201019 is, in the end, an endothelial disease","volume":"41","author":"Libby","year":"2020","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1111\/jth.15533_bb0100","doi-asserted-by":"crossref","first-page":"L1237","DOI":"10.1152\/ajplung.00202.2020","article-title":"P\u2010selectin blockade in COVID\u201019\u2010related ARDS","volume":"318","author":"Neri","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1111\/jth.15533_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-016-0013-6","article-title":"Complement\u2010targeted therapy: development of C5\u2010and C5a\u2010targeted inhibition","volume":"36","author":"Horiuchi","year":"2016","journal-title":"Inflamm Regen"},{"issue":"6","key":"10.1111\/jth.15533_bb0110","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1111\/bjh.16783","article-title":"Severe COVID\u201019 infection and thrombotic microangiopathy: success does not come easily","volume":"189","author":"Gavriilaki","year":"2020","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1111\/jth.15533_bb0115","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1111\/jth.15050","article-title":"Is the COVID\u201019 thrombotic catastrophe complement\u2010connected?","volume":"18","author":"Conway","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15533_bb0120","first-page":"100590","article-title":"Eculizumab as an emergency treatment for adult patients with severe COVID\u201019 in the intensive care unit: a proof\u2010of\u2010concept study","volume":"28","author":"Annane","year":"2020","journal-title":"Eclin Med"},{"issue":"8","key":"10.1111\/jth.15533_bb0125","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/MBC.0b013e32832da1e3","article-title":"The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity","volume":"20","author":"Echart","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"11","key":"10.1111\/jth.15533_bb0130","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1111\/jth.15021","article-title":"Multifactorial pathogenesis of COVID\u201019\u2010related coagulopathy: can defibrotide have a role in the early phases of coagulation disorders?","volume":"18","author":"Macci\u00f2","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1111\/jth.15533_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/bjh.17240","article-title":"COVID\u201019\u2010induced endotheliitis: emerging evidence and possible therapeutic strategies","volume":"193","author":"Calabretta","year":"2021","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1111\/jth.15533_bb0140","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1111\/jth.15100","article-title":"Defibrotide in the COVID\u201019 coagulopathy: What is the timing?","volume":"18","author":"Macci\u00f2","year":"2020","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15533","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15533","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622005542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622005542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:30:01Z","timestamp":1761535801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622005542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1538783622005542"],"URL":"https:\/\/doi.org\/10.1111\/jth.15533","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of novel antithrombotic agents for COVID\u201019: Systematic summary of ongoing randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}